2021学術賞・論文賞

2021年度 Drug Metabolism and Pharmacokinetics (DMPK) 「編集委員が選ぶ最優秀論文賞」Masuo Y, Fujita K, Mishiro K, Seba N, Kogi T, Okumura H, Matsumoto N, Kunishima M, and Kato Y*. 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug Metab Pharmacokinet 35(6): 555-562, 2020.

2021年度 Drug Metabolism and Pharmacokinetics (DMPK) 「編集委員が選ぶ最優秀論文賞」Masuo Y, Fujita K, Mishiro K, Seba N, Kogi T, Okumura H, Matsumoto N, Kunishima M, and Kato Y*. 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug Metab Pharmacokinet 35(6): 555-562, 2020.